Insights into the Role of Heme in the Mechanism of Action of Antimalarials

• Published in: ACS chemical biology Vol. 8; no. 1; pp. 133 - 137
• Main Authors: Combrinck, Jill M, Mabotha, Tebogo E, Ncokazi, Kanyile K, Ambele, Melvin A, Taylor, Dale, Smith, Peter J, Hoppe, Heinrich C, Egan, Timothy J
• Format: Journal Article
• Language: English
• Published: United States American Chemical Society 18-01-2013
• Subjects: Antimalarials - pharmacology; Chloroquine - pharmacology; Dose-Response Relationship, Drug; Heme - physiology; Microscopy, Electron, Transmission; Plasmodium falciparum - drug effects; Trophozoites - drug effects
• ISSN: 1554-8929; 1554-8937
• DOI: 10.1021/cb300454t

By using cell fractionation and measurement of Fe­(III)­heme-pyridine, the antimalarial chloroquine (CQ) has been shown to cause a dose-dependent decrease in hemozoin and concomitant increase in toxic free heme in cultured Plasmodium falciparum that is directly correlated with parasite survival. Transmission electron microscopy techniques have further shown that heme is redistributed from the parasite digestive vacuole to the cytoplasm and that CQ disrupts hemozoin crystal growth, resulting in mosaic boundaries in the crystals formed in the parasite. Extension of the cell fractionation study to other drugs has shown that artesunate, amodiaquine, lumefantrine, mefloquine, and quinine, all clinically important antimalarials, also inhibit hemozoin formation in the parasite cell, while the antifolate pyrimethamine and its combination with sulfadoxine do not. This study finally provides direct evidence in support of the hemozoin inhibition hypothesis for the mechanism of action of CQ and shows that other quinoline and related antimalarials inhibit cellular hemozoin formation.